The commercial software also reduced the median detection and notification time for incidental PE in flagged scans from “several days” down to just 1 hour.

The recall includes more than 1,500 devices distributed to customers from October 2021 to January 2023. 

The drug's manufacturer said it is working with retailers to get the drug on U.S. shelves and online for purchase by late summer.

HFpEF now accounts for a majority of heart failure cases, highlighting the importance of ensuring both primary care providers and dedicated heart teams know as much about this topic as possible. 

If great power obligates its wielder to exercise great responsibility, those advancing AI in healthcare are up to their necks in duty.

The recommendation is based on an analysis of mortality data from 415,000 U.S. women spanning 2011-2020. 

After high-risk medical devices go through the initial FDA approval process, it is relatively easy for manufacturers to get updates to those devices approved. New evidence suggests that this policy could be leading to more recalls, especially among cardiovascular devices.  

That’s according to an award-winning scientific online poster presented this week during the American Roentgen Ray Society’s annual meeting being held in Honolulu, Hawaii.